Ferofol-L Tablets represent pharmaceutical-grade iron supplementation manufactured under stringent quality control standards. Each sugar-coated tablet combines elemental iron from ...

Ferofol-L Tablets represent pharmaceutical-grade iron supplementation manufactured under stringent quality control standards. Each sugar-coated tablet combines elemental iron from Dried Ferrous Sulphate I.P 333 mg (equivalent to 100 mg elemental iron) with Folic Acid I.P 0.5 mg, ensuring optimal bioavailability and patient compliance. This precise formulation effectively addresses iron deficiency while enhancing erythrocyte production, making it a trusted solution for healthcare professionals and distributors seeking reliable anemia management products. The tablets' pharmaceutical-grade composition guarantees consistent therapeutic performance across diverse patient populations.

These tablets serve multiple healthcare sectors including hospital networks, clinical facilities, maternity care centers, and retail pharmacy chains. The pharmaceutical industry values Ferofol-L for its consistent performance in treating anemia across patient demographics, from pregnant women requiring prenatal support to individuals with chronic conditions affecting iron absorption. Distributors supply these tablets to government health programs, private healthcare institutions, and wellness organizations that prioritize evidence-based nutritional supplementation. The product's standardized formulation ensures reliable outcomes in various clinical and preventive healthcare settings.

For distributors and healthcare providers, Ferofol-L Tablets offer exceptional value through proven reliability, competitive pricing, and consistent therapeutic results. The product's pharmaceutical-grade quality builds trust among healthcare providers and end-users alike, supported by growing market demand for effective anemia solutions. Distributors benefit from the product's compliance with quality standards and its reputation for delivering predictable health outcomes across diverse patient populations. The tablets' established efficacy and safety profile make them a preferred choice for systematic anemia management programs.

Key Features:
- Contains 100 mg elemental iron from Ferrous Sulphate I.P for effective anemia treatment
- Includes 0.5 mg Folic Acid I.P to support healthy red blood cell formation
- Sugar-coated formulation for easy swallowing and reduced gastric irritation
- Manufactured under strict pharmaceutical quality control standards
- Consistent formulation ensures reliable therapeutic performance

Benefits:
- Effective treatment and prevention of iron deficiency anemia
- Supports healthy red blood cell production and oxygen transport
- Enhanced patient compliance through easy-to-swallow coating
- Guaranteed quality and safety through pharmaceutical manufacturing standards
- Reliable therapeutic outcomes for diverse patient populations